Is IDRA or XYLD a better dividend investment in 2026?

IDRA currently yields 470.59% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: IDRA offers higher current income.

What is the dividend yield difference between IDRA and XYLD?

IDRA has a forward dividend yield of 470.59% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 459.61 percentage points.

Home › Compare › IDRA vs XYLD

IDRA vs XYLD: Dividend Comparison 2026

IDRA yields 470.59% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IDRA wins by $38545.09M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IDRA

● Live price

470.59%

Share price

$0.43

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$38545.12M

Annual income

$27,182,357,871.92

Full IDRA calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — IDRA vs XYLD

📍 IDRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IDRA	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IDRA + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IDRA pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IDRA

Annual income on $10K today (after 15% tax)

$40,000.00/yr

After 10yr DRIP, annual income (after tax)

$23,105,004,191.13/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, IDRA beats the other by $23,105,001,454.96/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IDRA + XYLD for your $10,000?

IDRA: 50%XYLD: 50%

100% XYLD50/50100% IDRA

Portfolio after 10yr

$19272.57M

Annual income

$13,591,180,545.47/yr

Blended yield

70.52%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on IDRA right now

IDRA

Analyst Ratings

Buy

Hold

Consensus: Buy

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IDRA buys

XYLD buys

No recent congressional trades found for IDRA or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIDRAXYLD

Forward yield	470.59% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$38545.12M ✓	$25.3K
Annual income after 10y	$27,182,357,871.92 ✓	$3,219.02
Total dividends collected	$37542.88M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: IDRA vs XYLD ($10,000, DRIP)

Year	IDRA Portfolio	IDRA Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$57,759	$47,058.82	$10,818	$1,098.39	+$46.9K → IDRA
2	$315,826	$254,024.51	$11,738	$1,222.51	+$304.1K → IDRA
3	$1,636,076	$1,298,141.44	$12,774	$1,364.64	+$1.62M → IDRA
4	$8,035,425	$6,284,824.27	$13,944	$1,527.86	+$8.02M → IDRA
5	$37,445,846	$28,847,941.19	$15,270	$1,715.87	+$37.43M → IDRA
6	$165,706,448	$125,639,392.36	$16,775	$1,933.09	+$165.69M → IDRA
7	$696,916,266	$519,610,366.98	$18,490	$2,184.87	+$696.90M → IDRA
8	$2,788,074,169	$2,042,373,764.24	$20,450	$2,477.63	+$2788.05M → IDRA
9	$10,619,401,952	$7,636,162,591.12	$22,697	$2,819.19	+$10619.38M → IDRA
10	$38,545,117,961	$27,182,357,871.92	$25,280	$3,219.02	+$38545.09M → IDRA

IDRA vs XYLD: Complete Analysis 2026

IDRA — Stock

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Full IDRA Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this IDRA vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IDRA vs SCHD IDRA vs JEPI IDRA vs O IDRA vs KO IDRA vs MAIN IDRA vs QYLD IDRA vs JEPQ IDRA vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.